Risk Evaluation of Acute Exacerbation After pulmonary resection in Lung Cancer Patients with Interstitial Pneumonia (REVEAL-IP)

Risk Evaluation of Acute Exacerbation After pulmonary resection in Lung Cancer Patients with Interstitial Pneumonia (REVEAL-IP) - A validation of risk score system predicting post-operative acute exacerbation of interstitial pneumonia.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022626

Enrollment

1250

Registered

2016-06-06

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer Interstitial pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Small cell lung cancer patients with interstitial lung disease who are intended to have pulmonary resection. (2) Diagnosis of ILDs should be confirmed based on a combination of clinical and radiologic findings according to the clinical criteria proposed by the Japanese Respiratory Society, which are consistent with the guidelines of the American Thoracic Society in 2013. The cases are subjected to be categorized into 3 groups, according to their radiological appearance: 1. UIP, 2. Possible UIP, 3. Inconsistent with UIP pattern.

Exclusion criteria

Exclusion criteria: This is a prospective observational, non-invasive study. Exclusion criteria is not defined in order to guarantee the external validity of the findings, and to be a comprehensive registration and informations gathering.

Design outcomes

Primary

Measure	Time frame
Incident of acute-exacerbation during 30 days after pulmonary resection of lung cancer	—

Secondary

Measure	Time frame
Prognosis Cause of death	—

Countries

Japan

Contacts

Public ContactToshihiko Sato

Kyoto University Hospital Thpracic surgery

tsato@kuhp.kyoto-u.ac.jp075-751-4975

Outcome results